Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for E-cigarette Dependence
NCT05541497Phase 2Completed
- Sponsor
- Yale University
- Start
- Nov 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Varenicline with Placebo (2 arms). Primary endpoint: Number of Participants Abstinent From Vaping at Week 8. Started Nov 2022; status: completed.
02
Drugs
varenicline
Beyond the preview
Go deeper on NCT05541497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05541497.